LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that the Company expects results from the PREGNANT Study, a Phase III clinical trial evaluating PROCHIEVE® (progesterone gel), will be published in a respected peer-reviewed medical journal online next week, and in the journal’s print edition thereafter. The Company will issue a press release at the time of the online publication.
